<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.1//EN" "ep-patent-document-v1-1.dtd">
<ep-patent-document id="EP00943847B8W1" file="EP00943847W1B8.xml" lang="en" country="EP" doc-number="1189895" kind="B8" correction-code="W1" date-publ="20051109" status="c" dtd-version="ep-patent-document-v1-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYAL..............................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM350 (Ver 2.1 Jan 2001)
 2999001/0</B007EP><B070EP>The file contains technical information submitted after the application was filed and not included in this specification</B070EP></eptags></B000><B100><B110>1189895</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20051109</date></B140><B150><B151>W1</B151><B152><date>00000000</date></B152><B153>84</B153><B155><B1551>DE</B1551><B1552>Bibliographie</B1552><B1551>EN</B1551><B1552>Bibliography</B1552><B1551>FR</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>00943847.4</B210><B220><date>20000622</date></B220><B240><B241><date>20011115</date></B241><B242><date>20030929</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>9914977</B310><B320><date>19990625</date></B320><B330><ctry>GB</ctry></B330></B300><B400><B405><date>20051109</date><bnum>200545</bnum></B405><B430><date>20020327</date><bnum>200213</bnum></B430><B450><date>20050608</date><bnum>200523</bnum></B450><B452EP><date>20041217</date></B452EP><B480><date>20051109</date><bnum>200545</bnum></B480></B400><B500><B510><B516>7</B516><B511> 7C 07D 277/24   A</B511><B512> 7C 07D 277/26   B</B512><B512> 7C 07D 263/32   B</B512><B512> 7A 61K  31/421  B</B512><B512> 7A 61K  31/426  B</B512><B512> 7A 61P   3/10   B</B512></B510><B540><B541>de</B541><B542>THIAZOL- UND OXAZOL-DERIVATE UND IHRE PHARMAZEUTISCHE VERWENDUNG</B542><B541>en</B541><B542>THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE</B542><B541>fr</B541><B542>DERIVES DE THIAZOL ET D'OXAZOLE ET UTILISATION PHARMACEUTIQUE DE CEUX-CI</B542></B540><B560><B561><text>WO-A-97/28149</text></B561><B561><text>WO-A-98/07699</text></B561><B561><text>WO-A-99/04815</text></B561><B561><text>WO-A-99/46232</text></B561><B561><text>US-A- 5 847 008</text></B561><B562><text>PATENT ABSTRACTS OF JAPAN vol. 1997, no. 04, 30 April 1997 (1997-04-30) &amp; JP 08 325250 A (SUMITOMO METAL IND LTD), 10 December 1996 (1996-12-10) -&amp; JP 08 325250 A 10 December 1996 (1996-12-10)</text></B562><B562><text>H. SHINKAI ET AL.: JOURNAL OF MEDICINAL CHEMISTRY, vol. 41, no. 11, 1998, pages 1927-33, XP002151949</text></B562></B560></B500><B700><B720><B721><snm>CHAO, Esther, Yu-Hsuan</snm><adr><str>Glaxo Wellcome Inc.,
Five More Drive</str><city>Research Triangle Park, NC 27709</city><ctry>US</ctry></adr></B721><B721><snm>HAFFNER, Curt, Dale</snm><adr><str>Glaxo Wellcome Inc.,
Five Moore Drive</str><city>Research Triangle Park, NC 27709</city><ctry>US</ctry></adr></B721><B721><snm>LAMBERT, Millard, Hurst, III</snm><adr><str>Glaxo Wellcome Inc.,
Five Moore Drive</str><city>Research Triangle Park, NC 27709</city><ctry>US</ctry></adr></B721><B721><snm>MALONEY, Patrick, Reed</snm><adr><str>Glaxo Wellcome Inc.,
Five Moore Drive</str><city>Research Triangle Park, NC 27709</city><ctry>US</ctry></adr></B721><B721><snm>SIERRA, Michael, Lawrence</snm><adr><str>Z A de Courtaboeuf,
25, avenue de Quebec</str><city>91940 Les Ulis</city><ctry>FR</ctry></adr></B721><B721><snm>STERNBACH, Daniel, David</snm><adr><str>Glaxo Wellcome Inc.,
Five Moore Drive</str><city>Research Triangle Park, NC 27709</city><ctry>US</ctry></adr></B721><B721><snm>SZNAIDMAN, Marcos, Luis</snm><adr><str>5222 Greyfield Boulevard</str><city>Durham, NC 27713</city><ctry>US</ctry></adr></B721><B721><snm>WILLSON, Timothy, Mark</snm><adr><str>Glaxo Wellcome Inc.,
Five Moore Drive</str><city>Research Triangle Park, NC 27709</city><ctry>US</ctry></adr></B721><B721><snm>XU, Huaqiang, Eric</snm><adr><str>Glaxo Wellcome Inc.,
Five Moore Drive</str><city>Research Triangle Park, NC 27709</city><ctry>US</ctry></adr></B721><B721><snm>GELLIBERT, Françoise, Jeanne,
Lab. Glaxo Wellcome</snm><adr><str>ZA de Courtaboeuf,
25 Avenue de Quebec</str><city>91940 Les Ulis</city><ctry>FR</ctry></adr></B721></B720><B730><B731><snm>SMITHKLINE BEECHAM CORPORATION</snm><iid>02408951</iid><irf>PU3645/EPw</irf><adr><str>One Franklin Plaza, 
P.O. Box 7929</str><city>Philadelphia, Pennsylvania 19101</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Learoyd, Stephanie Anne</snm><sfx>et al</sfx><iid>00079784</iid><adr><str>GlaxoSmithKline 
Two New 
Horizons Court 
Horizons Court</str><city>Brentford, Middlesex TW8 9GS</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B844EP><B845EP><ctry>SI</ctry><date>20011115</date></B845EP></B844EP><B860><B861><dnum><anum>EP2000005720</anum></dnum><date>20000622</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2001000603</pnum></dnum><date>20010104</date><bnum>200101</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
